Drug Shortage Report for NAPROSYN
Report ID | 181466 |
Drug Identification Number | 02162466 |
Brand name | NAPROSYN |
Common or Proper name | Naproxen sustained release tablets |
Company Name | ATNAHS PHARMA UK LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | NAPROXEN |
Strength(s) | 750MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100s |
ATC code | M01AE |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2023-01-19 |
Actual start date | 2023-01-19 |
Estimated end date | Unknown |
Actual end date | 2023-05-25 |
Shortage status | Resolved |
Updated date | 2023-05-26 |
Company comments | Batch released |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | SOVEREIGN HOUSE, MILES GRAY ROAD BASILDON, ESSEX GREAT BRITAIN SS14 3FR |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2023-05-26 | English | Compare |
v6 | 2023-05-25 | French | Compare |
v5 | 2023-05-25 | English | Compare |
v4 | 2023-05-25 | English | Compare |
v3 | 2023-01-20 | English | Compare |
v2 | 2023-01-18 | French | Compare |
v1 | 2023-01-18 | English | Compare |
Showing 1 to 7 of 7